AccurKardia

We're excited to share this insightful podcast featuring our very own Ken Nelson — a cardiac monitoring veteran, investor, and Strategic Advisor at AccurKardia. In this engaging conversation with Omar M. Khateeb, Ken dives into the latest innovations in cardiactech, and his unique perspective on healthcare investments is truly inspiring. Tune in to hear his journey and vision for the future of cardiac care. Check out the full discussion here: https://lnkd.in/eDRs3mZD #MedTech #Cardiology #HealthcareInvestment #Innovation #AccurKardia

ECGs: A Window into Whole-Body Health We’ve long believed that an ECG is far more than just a heart test. A groundbreaking new study using unsupervised deep learning found 645 prevalent and 606 incident disease associations in ECGs—spanning cardiac, respiratory, endocrine, and more. Even rheumatoid arthritis, which has no classic ECG signature, revealed subtle waveform changes. Why It Matters: This research strongly supports our view of ECGs as a “digital biomarker” for overall health. By harnessing AI and powerful computing, we can unlock hidden signals that transform a routine ECG into a far-reaching screening tool. Check out the full publication: Unsupervised Deep Learning of ECGs Enables Scalable Human Disease Profiling by Sam Friedman, et al. https://lnkd.in/e5YRmNSG Key Takeaways: *Broad Disease Detection: ECG signals hint at conditions from hypertension to diabetes. *Subclinical Insights: Deep learning uncovers waveform patterns traditional interpretation may miss. *Big Opportunity: Wearable ECG data + AI = noninvasive, population-level health monitoring. #BetterOutcomes #ECG #EKG #Innovation #AI

We’re proud to share a snapshot from our company-wide call where the team wore red in support of National Wear Red Day! Together, we’re raising awareness about the importance of heart health for women everywhere. By uniting our passion for better outcomes, we can help make a positive impact—one heartbeat at a time.

This Friday, AccurKardia is proud to join the movement on National Wear Red Day® in support of women's heart health! In celebration of American Heart Month, we're taking action to empower healthier lifestyles and stronger communities. Join us in connecting to a healthier you: Learn: Gain insights into risk reduction, prevention, and healthy living. Engage: Participate in community events and support networks. Empower: Inspire the next generation through research and STEM careers. Let’s rock our red, share our stories, and create a ripple effect of awareness. How are you showing your support? Comment below and let’s inspire each other! Discover more ways to get connected at GoRedforWomen.org #WearRedDay #HeartMonth #WomenHealth #Innovation #BetterOutcomes

We're thrilled to announce that our new website is live! Dive into how we're transforming ECGs into a more powerful diagnostic tool and broad biomarker—with breakthrough applications in cardiology and beyond. Explore the future of heart health at www.accurkardia.com and join us in our mission to improve patient outcomes and save lives.

February is American Heart Month—a time to spotlight the importance of cardiovascular health and proactive care. This month, we encourage everyone to take a moment to learn about the risk factors, preventive measures, and lifestyle changes that can make a lasting impact on heart health. Discover more about how you can contribute to a healthier future by visiting trusted resources like the American Heart Association. Together, let’s champion heart health—one ECG at a time. #AmericanHeartMonth #HeartHealth #CardiovascularCare #BetterOutcomes #Innovation

Hyperkalemia is a serious concern for patients with CKD and ESRD, but real-time remote detection can make a critical difference. In this Nephrology Times/DocWire News interview, Dr. Wei Ling Lau (https://lnkd.in/eW7EpX2r) discusses how AK+ Guard™ uses Lead I ECG data for earlier intervention and improved outcomes. https://lnkd.in/eHXdxgJv #Hyperkalemia #AI #ECG #CKD #ESRD #Innovation #DigitalHealth #BetterOutcomes

Get caught up on the biggest cardiology stories from last week, with news from MedAxiom - An ACC Company Matthew Budoff Boston Scientific Bolt Medical Novo Nordisk Alleviant Medical Sammy Sayed Anumana AliveCor AccurKardia Arunashis Sau

This week the LSI Alumni secured $381M in funding, entered new partnerships, appointed new executives, and much more on the road to LSI USA ‘25. You 60-second news recap: AccurKardia → FDA Breakthrough Device Designation for its AI-powered hyperkalemia detection software using Lead I ECG data. Arcuro Medical → Initial close of a Series A funding round led by Varana Capital. Aspect Biosystems → Raised $115M in a Series B funding round led by Dimension. Caresyntax and Qaelon Medical → LSI Alumni Caresyntax and Qaelon Medical partnered to address the devastating impact of surgical leaks. Caresyntax and Roivios, Ltd. → LSI Alumni Caresyntax and Roivios joined forces to revolutionize renal care through data-driven insights. CeQur → Raised a $120M equity funding round. Francis Medical → Raised $80M in oversubscribed Series C equity financing. Mendaera, Inc. → Appointed Eric Davidson as Chief Commercial Officer. NOVADIP Biosciences S.A. → Appointed Drew Trivisonno to its Board of Directors. NUA SURGICAL → Welcomed Anna Nestor to its leadership team as a VP of Quality. Onera Health → Appointed Maria Sainz as Chair of its Board of Directors. Onkos Surgical → Completed its first-in-human cases using its NanoCEPT antibacterial technology. → Also secured a $35M venture loan facility from Horizon Technology Finance. Prana Surgical → Announced a name change from Prana Thoracic to Prana Surgical. Pristine Surgical → Announced that its Summit platform secured a Defense Logistics Agency (DLA) ECAT contract. ScreenPoint Medical → Announced the acquisition of BioMediq A/S to expand its breast cancer risk assessment capabilities. Simpson Interventions → IDE approval from the FDA for its Acolyte Catheter System and 510(k) clearance for its Shadow Catheter. Single Pass, Inc. → Appointed Dan Hughes as its Commercial Lead. SpectraWAVE, Inc. → Appointed Brad Davis as Chief Commercial Officer and Bill Kelly as Chief Financial Officer. Spiro Robotics → Completed its first-in-human trial for its Spiro-Vista tracheal intubation device. Stimdia Medical → Appointed Allen Meacham as its new CEO. THINK Surgical → Announced the first use of Medacta International’s GMK Sphere implant with its TMINI Miniature Robotic System. Vensana Capital → Closed its third fund, raising $425M to invest in breakthrough medical technology companies. Vitestro → Appointed Bob Gerberich as Chief Commercial Officer for North America. Wellumio → Expanded its global footprint in the U.S. market via its launch of a new subsidiary in California. Xeltis → Completed enrollment in its EU pivotal trial for its aXess technology. Zeto / Rapid Full-Montage EEG → Raised $31M in a Series B funding round. Congratulations to all the LSI Alumni who made major news this week!

AccurKardia’s CEO, Juan C Jimenez will be in San Francisco this coming week! If you’re looking to learn how our technology is redefining ECGs as a more powerful diagnostic tool and broad biomarker, let’s connect. Reach out to info@accurkardia.com to schedule a meeting and discover how AccurECG™ (FDA Cleared Class II SaMD), AK-AVS™, and AK+ Guard™ are transforming cardiovascular and renal care. We look forward to meeting you and exploring how we can shape the future of healthcare together! To learn more: AccurECG: https://lnkd.in/eVsubC93 AK-AVS: https://lnkd.in/dYJ6w4JN AK+ Guard: https://lnkd.in/g7CJuTX7